San Diego-based biopharmaceutical company KymaThera has successfully closed an $80 million Series B financing round to propel its lead oncology…
Read More

San Diego-based biopharmaceutical company KymaThera has successfully closed an $80 million Series B financing round to propel its lead oncology…
Read More